Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > This constant selling...........

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon May 27, 2022 11:06am

262 Views

Post# 34712141

RE:RE:RE:RE:RE:This constant selling...........

I think we will get AA early 2nd qtr 2023. Yes Laser. I think that is what they mean by commercial revenues. Selling 1433 to urologists in the US with an, conditionally, FDA approved product. They will likely need some partner for this as they don't currently have the resources to market distribute and manufacture all the different pieces of their ACT. At least not to Scale...

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta